Glenmark Pharmaceuticals Ltd.
Share Price Target & Analysis

NSE:GLENMARK

2198.57

VWAP

2232

Open

2209.6

Close

2252.5

High

2137.1

Low

2474

52 Week High

2144.40 ⇩
-65.20 (-2.95%)

GLENMARK

(PHARMA)
62.8% Momentum

Sideways to Positive

1589

52 Week Low

N/A

EPS

47.91

PE

2.5

PB

Uncertain
Quality

Unclear
Valuation

#Analysis

NSE: GLENMARK Share Price Financial Analysis & Valuation

Glenmark Pharmaceuticals Ltd. (GLENMARK) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Mid Cap company with Market Capitalization of Rs 13448.1 (in Cr). Total number of free float shares are 0 (in Lacs). Glenmark Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE935A01035 and trading code is NSE:GLENMARK with short name Glenmark.

Glenmark Pharmaceuticals Ltd. is also traded in Future & Options (Derivative segment of NSE).

In the past 1 year, Glenmark Pharmaceuticals Ltd. has declared an equity dividend of Rs 5 per share. At the current share price of GLENMARK at Rs 2144.40, this results in a dividend yield of 0.23 %.

As per the Fundamental Analysis of NSE:GLENMARK, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLENMARK underlying value and future prospects. All of this data is available in GLENMARK financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:GLENMARK, it is clearly understood that GLENMARK is Uncertain performer in terms of earnings and profit margins with an EPS of 0. NSE:GLENMARK book value per share as of today is 858.31. The current price to book ratio for GLENMARK as of Jun 11, 2026 is 2.5.

Valuation of the Stock: The current valuation of GLENMARK stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLENMARK whether to BUY this stock at current valuation. The delivery percentage of GLENMARK is 43.44% is very crucial parameter which shows that 43.44% investors are anticipating that the price of GLENMARK share should go up with VWAP at 2198.57.

Now, the main question is whether to BUY or SELL, NSE:GLENMARK at current valuation.
As per latest Analysis No. #1715:-

⇑ STRONG BUY GLENMARK if All Greens

⇗ BUY GLENMARK (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD GLENMARK (With Stop Loss) if only 1 Green

⇘ SELL GLENMARK if NO Green Indicator

NSE: GLENMARK Share Price Today (Jun 11, 2026)

(Glenmark Pharmaceuticals Ltd. Daily Analysis on the basis of GLENMARK Intraday Graph & Trend)

Glenmark Pharmaceuticals Ltd. share price moved Down by -2.95% from its previous close of Rs 2209.6. GLENMARK stock last traded price is 2144.40. GLENMARK share price trend is Down with a total of 1127230 stocks traded till now. It has touched an intraday high of Rs 2252.5 and an intraday low of Rs 2137.1. The GLENMARK trading at 2144.40, Down by Rs. -65.20, or -2.95 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down.

NSE: GLENMARK Share Price Tomorrow Prediction

(Glenmark Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLENMARK)

Glenmark Pharmaceuticals Ltd. share price moved Down by -2.95%. GLENMARK share price short term trend is Down. It suggests that GLENMARK Share Price for Tomorrow remains the same with VWAP at 2198.57 will be treated as stop loss for intraday traders. Glenmark Pharmaceuticals Ltd. Long term investors can follow the GLENMARK long term trend as mentiond in future forecast table.

NSE Code

NSE: GLENMARK

GLENMARK Share Price Today

 2144.40

GLENMARK Share Price Target Prediction for 2026 ^

 1952.5 - 2486.2

GLENMARK Share Price Target Prediction for 2027*^

 2486.2 - 2585.6

GLENMARK Share Price Target Prediction for 2028*^

 2585.6 - 2714.9

GLENMARK Share Price Target Prediction for 2029*^

 2851

GLENMARK Share Price Target Prediction for 2030*^

 2878

GLENMARK Share Price Target Prediction for 2035*^

 3108
GLENMARK Current Book Value 2025
854

*Glenmark Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLENMARK share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

GLENMARK Technical Analysis

Candlestick Pattern: @2181.1

GLENMARK Moving Averages

BUY (14) NEUTRAL (0) SELL (0)
MA Simple Action S1 Expo Action E2
MA_5 1918.9 BUY 1957.5 BUY
MA_12 1818.98 BUY 1843.53 BUY
MA_20 1764.38 BUY 1786.1 BUY
MA_32 1669.86 BUY 1706.66 BUY
MA_50 1590.67 BUY 1649.11 BUY
MA_100 1518.52 BUY 1580.57 BUY
MA_200 1541.95 BUY 1498.98 BUY

GLENMARK Trend Oscillators

BUY (4) NEUTRAL (0) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 2007.43 OverBought
MACD 26.02 BUY
ADX 52.86 Very Strong Trend
DMI (+/-) 64.03 / 5.72 Uptrend

GLENMARK Momentum Oscillators

BUY (6) NEUTRAL (6) SELL (0)
Momentum Oscillators Value Action
RSI 88.37 Overbought
STOCHASTIC_K (Fast) 78.89 Neutral
STOCHASTIC_D (Slow) 69.52 Neutral
CCI 317.8 BUY
PSAR 1792.6 BUY
TRUE RANGE 380.8 Neutral
ATR 69.92 Neutral
WILLIAMS R -16.99 Overbought
TRIX 0 Neutral
STOCHASTIC RSI K 100 Overbought
STOCHASTIC RSI D 53.15 Neutral
MOMENTUM 541.5 BUY

GLENMARK Last 1 Year Trend

Duration Value
1 Year 60.49%
3 Months 51.23%
1 Month 33.03%
1 Week 19.16%

GLENMARK Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 80%
NEUTRAL / HOLD 20%
SELL 0%

Most popular Questions & Answers about GLENMARK


Glenmark Pharmaceuticals Ltd. stock last traded price is 2144.40. GLENMARK share price moved Down by -2.95% from its previous close of Rs 2209.6.

Glenmark Pharmaceuticals Ltd. share price trend is Down with a total of 1127230 stocks traded till now. It has touched an intraday high of Rs 2498.74 and an intraday low of Rs 2137.1. The GLENMARK trading at 2144.40, Down by Rs. -65.20, or -2.95 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down and the Stop Loss will be around 2198.57.

The market cap of Glenmark Pharmaceuticals Ltd. is ₹13448.1 (in Cr) as of Jun 10, 2026.

The current price to earning ratio for Glenmark Pharmaceuticals Ltd. as of Jun 10, 2026 is 47.91.

The current price to book ratio for Glenmark Pharmaceuticals Ltd. as of Jun 10, 2026 is 2.5.

The highest price of Glenmark Pharmaceuticals Ltd. stock is ₹2474 in the last 52-week.

The lowest price of Glenmark Pharmaceuticals Ltd. stock is ₹1589 in the last 52-week.

Glenmark Pharmaceuticals Ltd. share trading at ₹2144.40, Down by Rs. -65.20, or -2.95 percent which suggests that most of the traders are anticipating that the price of GLENMARK share should go Down.

In 2025, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1952.5 on downside and ₹2486.2 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.

In 2026, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2486.2 on downside and ₹2585.6 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2585.6 on downside and ₹2714.9 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2878 Glenmark Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLENMARK.

The price of Glenmark Pharmaceuticals Ltd. (GLENMARK) shares moved by -2.95%. The short-term trend for GLENMARK share price is Down. It implies that the share price of GLENMARK will stay the same tomorrow and that intraday traders should treat VWAP at 2198.57 as a stop loss. Investors with a long-term outlook can track GLENMARK long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of GLENMARK stock is Unavailable at this moment. Compared to the current market price of 2144.40 INR, the GLENMARK stock is unpredictable by lack of Insufficient data.

As per the fundamental analysis of Glenmark Pharmaceuticals Ltd. (GLENMARK), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0. Glenmark Pharmaceuticals Ltd. book value per share as of today is 858.31. The current price to book ratio for GLENMARK as of Jun 11, 2026 is 2.5.


NSE:GLENMARK News & Other Useful Information about GLENMARK Share Price


Peer Comparison of NSE: GLENMARK

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1786.40 10.97 102.19
DIVISLAB 6638.50 98.2 600.79
MEDICAMEQ 230.10 6.94 202.47
CIPLA 1377.00 43.51 419.16
DRREDDY 1271.70 38.57 378.63
PGHH 5215.00 189.8 373.34
TORNTPHARM 4463.70 64.77 266.87
BIOCON 414.60 0.23 99.01
LUPIN 2247.20 139.24 611.12
ALKEM 5299.50 190.87 1194.91
Updated at: 10 Jun 2026 15:59

Feel free to contact us, in case of any queries.

SITEMAP 608
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2931.10 -48.80 (-1.64%) | ADANIGREEN 1483.00 -51.50 (-3.36%) | ADANIPORTS 1821.20 -5.20 (-0.28%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 409.80 -6.20 (-1.49%) | APOLLOHOSP 8488.50 -35.50 (-0.42%) | ASIANPAINT 2715.10 7.00 (0.26%) | ATGL 728.40 -23.75 (-3.16%) | AUROPHARMA 1453.60 4.60 (0.32%) | AXISBANK 1314.50 22.10 (1.71%) | BAJAJ-AUTO 10144.00 -40.00 (-0.39%) | BAJAJFINSV 1664.20 -28.90 (-1.71%) | BAJFINANCE 884.10 -2.80 (-0.32%) | BALKRISIND 2083.20 -44.60 (-2.1%) | BANDHANBNK 199.76 -7.18 (-3.47%) | BANKBARODA 269.30 -4.45 (-1.63%) | BEL 408.35 -3.70 (-0.9%) | BERGEPAINT 516.70 14.80 (2.95%) | BHARTIARTL 1775.20 -23.80 (-1.32%) | BIOCON 414.60 -1.75 (-0.42%) | BOSCHLTD 37790.00 -30.00 (-0.08%) | BPCL 288.00 -1.10 (-0.38%) | BRITANNIA 5171.00 63.50 (1.24%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1377.00 0.50 (0.04%) | COALINDIA 451.00 -15.90 (-3.41%) | COLPAL 2056.30 32.90 (1.63%) | DABUR 427.90 1.75 (0.41%) | DIVISLAB 6638.50 -114.50 (-1.7%) | DLF 563.20 -11.95 (-2.08%) | DMART 4043.40 -48.60 (-1.19%) | DRREDDY 1271.70 3.20 (0.25%) | EICHERMOT 7219.50 16.50 (0.23%) | GAIL 168.01 0.42 (0.25%) | GLAND 2267.80 -20.70 (-0.9%) | GODREJCP 1027.60 14.40 (1.42%) | GRASIM 3071.20 -24.30 (-0.79%) | GUJGASLTD 381.30 -10.85 (-2.77%) | HAVELLS 1155.50 5.00 (0.43%) | HCLTECH 1132.10 -14.20 (-1.24%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2447.80 -55.50 (-2.22%) | HDFCBANK 746.85 8.50 (1.15%) | HDFCLIFE 549.55 -11.05 (-1.97%) | HEROMOTOCO 4856.70 1.30 (0.03%) | HINDALCO 1039.30 -37.40 (-3.47%) | HINDUNILVR 2169.50 36.70 (1.72%) | HINDZINC 547.55 -16.10 (-2.86%) | ICICIBANK 1293.30 18.30 (1.44%) | ICICIGI 1732.20 -45.50 (-2.56%) | ICICIPRULI 465.80 -8.95 (-1.89%) | INDIGO 4524.90 -12.70 (-0.28%) | INDUSINDBK 883.95 -38.85 (-4.21%) | INDUSTOWER 413.15 -6.25 (-1.49%) | INFY 1145.30 -35.00 (-2.97%) | IOB 33.26 -0.17 (-0.51%) | IOC 136.88 -1.25 (-0.9%) | ITC 283.65 3.65 (1.3%) | JSWSTEEL 1269.80 8.10 (0.64%) | KOTAKBANK 388.10 6.40 (1.68%) | LT 3917.50 16.90 (0.43%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2247.20 -17.00 (-0.75%) | M&M 2952.50 -37.60 (-1.26%) | MARICO 819.90 6.70 (0.82%) | MARUTI 13073.00 -47.00 (-0.36%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 2898.80 -92.30 (-3.09%) | NAUKRI 971.25 -11.35 (-1.16%) | NESTLEIND 1438.30 27.90 (1.98%) | NMDC 88.45 -1.59 (-1.77%) | NTPC 351.65 -4.00 (-1.12%) | ONGC 251.90 -7.10 (-2.74%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1506.50 24.70 (1.67%) | PIIND 2807.70 -58.70 (-2.05%) | PNB 107.17 -2.48 (-2.26%) | POWERGRID 287.20 1.50 (0.53%) | RELIANCE 1258.80 -10.40 (-0.82%) | SAIL 181.72 -4.27 (-2.3%) | SBICARD 580.70 -4.25 (-0.73%) | SBILIFE 1728.70 -40.40 (-2.28%) | SBIN 1003.25 0.55 (0.05%) | SHREECEM 23850.00 435.00 (1.86%) | SIEMENS 3582.70 -37.10 (-1.02%) | SRF 2734.10 44.50 (1.65%) | SUNPHARMA 1786.40 7.40 (0.42%) | TATACONSUM 1108.00 1.50 (0.14%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 199.31 -3.87 (-1.9%) | TCS 2153.90 2.90 (0.13%) | TECHM 1478.90 -4.90 (-0.33%) | TITAN 4042.10 -62.80 (-1.53%) | TORNTPHARM 4463.70 -9.20 (-0.21%) | ULTRACEMCO 10866.00 -45.00 (-0.41%) | UPL 611.00 -17.40 (-2.77%) | VEDL 299.30 -6.95 (-2.27%) | WIPRO 178.93 -2.74 (-1.51%) |